Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2018 Jan 31;84(4):e02595-17. doi: 10.1128/AEM.02595-17

Poly-3-Hydroxybutyrate Functionalization with BioF-Tagged Recombinant Proteins

Daniel Bello-Gil a,*, Beatriz Maestro a,*, Jennifer Fonseca a, Nina Dinjaski b,*, M Auxiliadora Prieto b, Jesús M Sanz a,*,
Editor: Ning-Yi Zhouc
PMCID: PMC5795070  PMID: 29196289

ABSTRACT

Polyhydroxyalkanoates (PHAs) are biodegradable polyesters that accumulate in the cytoplasm of certain bacteria. One promising biotechnological application utilizes these biopolymers as supports for protein immobilization. Here, the PHA-binding domain of the Pseudomonas putida KT2440 PhaF phasin (BioF polypeptide) was investigated as an affinity tag for the in vitro functionalization of poly-3-hydroxybutyrate (PHB) particles with recombinant proteins, namely, full-length PhaF and two fusion proteins tagged to BioF (BioF–C-LytA and BioF–β-galactosidase, containing the choline-binding module C-LytA and the β-galactosidase enzyme, respectively). The protein-biopolyester interaction was strong and stable at a wide range of pHs and temperatures, and the bound protein was highly protected from self-degradation, while the binding strength could be modulated by coating with amphiphilic compounds. Finally, BioF–β-galactosidase displayed very stable enzymatic activity after several continuous activity-plus-washing cycles when immobilized in a minibioreactor. Our results demonstrate the potentialities of PHA and the BioF tag for the construction of novel bioactive materials.

IMPORTANCE Our results confirm the biotechnological potential of the BioF affinity tag as a versatile tool for functionalizing PHA supports with recombinant proteins, leading to novel bioactive materials. The wide substrate range of the BioF tag presumably enables protein immobilization in vitro of virtually all natural PHAs as well as blends, copolymers, or artificial chemically modified derivatives with novel physicochemical properties. Moreover, the strength of protein adsorption may be easily modulated by varying the coating of the support, providing new perspectives for the engineering of bioactive materials that require a tight control of protein loading.

KEYWORDS: PHB, phasins, affinity tag, protein immobilization, polyhydroxyalkanoates

INTRODUCTION

The immobilization of peptides and proteins on polymer surfaces to develop bioactive supports represents a challenging goal in biotechnology and biomedicine (1, 2). As more biotechnologically relevant materials with new properties are described, novel methods for efficient protein functionalization are also required. Among the immobilization procedures, covalent methods ensure the strongest binding to the support, providing, in some cases, even more stability to the immobilized protein. However, the matrix is barely recoverable after enzyme inactivation, and these methods normally require the use of chemical-linking reagents that might perturb the native structure of the polypeptide (although interesting, alternative in situ systems have been recently described) (3). On the other hand, noncovalent methods are generally of a weaker intensity but have other important advantages, as they are normally simple and gentle and do not require the chemical modification of the protein, thus diminishing the risk of denaturation. In addition, immobilization is reversible in most cases, enabling the straightforward regeneration of the support (4, 5).

Current trends in material research specifically focus on biocompatible and biodegradable, yet versatile and stable, supports. The polyhydroxyalkanoate (PHA) family possesses all these characteristics. PHAs are natural polyesters of 3-hydroxyalkanoic acids that accumulate intracellularly in several organisms as a reserve material. They possess a high variety of monomer compositions, providing them with different physicochemical properties and functionalities (69). Depending on the length of the carbon chain, PHAs are classified as (i) short-chain-length PHAs (scl-PHAs; 3 to 5 carbon atoms), (ii) medium-chain-length PHAs (mcl-PHAs; 6 to 14 carbon atoms), or (iii) long-chain-length PHAs (lcl-PHAs; more than 14 carbon atoms) (10). The scl-PHA poly-3-hydroxybutyrate (PHB) represents the most produced and commercially successful member of the PHA family (11, 12). The PHAs constitute, among natural polymers, the largest group of microbial polyesters that displays thermoplastic features (9, 13) (hence the commonly used term “bioplastics”). They have been hailed as potential competitors of oil-derived plastics, not only because of their physical properties but also for their biocompatibility and biodegradability (8, 14, 15) and the high sustainability of their sources, as they naturally accumulate as a reserve material in several microbial (16) and engineered plant (17) species. The tunable structural features of these polyesters based on their variable compositions make them highly attractive for the development of next-generation biomaterials capable of being functionalized with peptides and proteins.

Native PHA granules are subcellular structures formed by a polymeric core surrounded by granule-associated proteins (GAPs) (18). Microbial PHA preparations usually contain adsorbed phospholipids as well (19), although the actual occurrence of this coating in vivo has been recently questioned and might represent a purification artifact from the cell extracts (2022). Phasins, the main component of GAPs, have a relevant role in the PHA intracellular metabolism, participating in events that include the control of the size, number, and localization of granules in the cell (23, 24). The high affinity of phasins for PHA suggests the application of such polypeptides as affinity tags for the immobilization of proteins on polyester granules. Despite its potential, only a few examples of phasin-mediated immobilization of recombinant proteins have been described to date (2531). In particular, Prieto and coworkers (32) developed the BioF tag derived from the PHA-binding domain of the PhaF phasin from Pseudomonas putida KT2440, a protein that is involved in the intracellular stabilization and localization of the PHA granule as well as in its equal distribution between daughter cells upon cell division, due to the presence of a DNA-binding domain (33, 34). Several fusion proteins containing the BioF sequence were expressed and found to be associated in vivo with native mcl-PHA granules in P. putida without compromising its functionality (32). The fusion proteins could be recovered from the granules by a mild treatment with detergents. In a step toward effective biotechnological applications, native granules containing a variant of the Cry1Ab toxin with insecticidal properties were produced (35), demonstrating that the functionalization of PHA polyesters with BioF-tagged proteins constitutes a promising field for designing bioactive polymers of interest. However, several aspects of these in vivo systems need be addressed for their successful application, such as the control of granule size and the amount of immobilized protein, as well as the overall conditions of the environment regulating its binding (pH, temperature, etc.).

To date, most studies have dealt with the interaction between a particular PHA and the cognate phasin with which it naturally interacts in vivo, but the peculiar organization of phasins as predominantly amphipathic α-helical proteins that recognize the biopolymer through relatively nonspecific interactions (23) enables speculation on the possibility of a wider PHA substrate range for this family of polypeptides. It is also evident that a single versatile tag able to recognize different types of PHAs would imply an important biotechnological capacity. Therefore, we decided to characterize the binding of several BioF fusions to scl-PHA particles such as PHB. Although several phasins naturally bound to PHB inclusions have been described (23, 24), our approach considered the aim of expanding the applications of the BioF tag (a naturally mcl-PHA-binding polypeptide) rather than finding a strong tag strictly recognizing a particular PHA. Furthermore, we have assessed the functional performance of a BioF–β-galactosidase hybrid protein immobilized on PHB as a proof of concept for the development of PHA-based enzymatic bioreactors. We believe that our results confirm that BioF-based PHA functionalization procedures possess an evident potential in biomedicine and bioprocess technology.

RESULTS

In vitro interaction of the PhaF phasin with lipid/GAP-free PHB particles.

The binding capability of the BioF polypeptide to mcl-PHA granules has been widely demonstrated in vivo (32, 35, 36). Nevertheless, native PHA granules are surface coated by several GAPs and probably by a lipid layer that might interfere with the BioF binding in vivo. Therefore, in a first approach, we tested the ability of the entire PhaF phasin to be immobilized in vitro on commercially available PHB particles devoid of any protein or lipid coating. Figure 1 shows that, in sodium phosphate (PNa) buffer at 25°C or 37°C, PhaF could be clearly adsorbed on PHB, indicating that the substrate range of the BioF tag also includes scl-PHAs and that no other granule-associated components are needed for efficient binding.

FIG 1.

FIG 1

(Left) Stability of PhaF binding to PHB at 25 and 37°C analyzed by SDS-PAGE. C, control of soluble protein; B, bound protein eluted from PHB with 1% (wt/vol) SDS after heating at 90°C for 10 min. (Right) Results of gel densitometry, shown as the percentages of the initial applied protein. Black solid bars indicate soluble control protein, whereas red hashed bars represent the particle-bound protein.

The stability of this PhaF-PHB interaction was evaluated at both 25 and 37°C. After 48 h of incubation, approximately 65% of the initially added PhaF (representing 75% of the initially bound protein) remained stably attached to the polyester at both temperatures without significant hints of protein degradation (Fig. 1). Furthermore, incubation at pHs other than 7.0 did not appear to have a direct influence on immobilization, as the protein remained similarly adsorbed to the particles in all cases (see Fig. S3 in the supplemental material). This result supports the hypothesis that ionic forces are minor contributors to PHA recognition (34). To test the strength of the hydrophobic interactions, protein desorption was induced by incubations with several detergents at 25°C (Fig. 2A; see also Fig. S4). PhaF was eluted from the polymer particles with the greatest efficiency by SDS and sarcosyl, and only partially (18%) with Tween 20 (Fig. 2A). However, other detergents such as Triton X-100, 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), and sodium cholate were unable to desorb the protein at the concentrations tested (Fig. 2A).

FIG 2.

FIG 2

Elution of PhaF from different preparations of PHB upon incubation with detergents and the dependence on granule coating. (Left panel) SDS-PAGE analysis. C, control of soluble protein; SDS, 1% (wt/vol) SDS; Tr, 1% (vol/vol) Triton X-100; Tw, 1% (wt/vol) Tween 20; Ch, 3% (wt/vol) CHAPS; Co, 3% (wt/vol) sodium cholate; Sc, 3% (wt/vol) sarcosyl. (A) Naked PHB; (B) PHB coated with sodium oleate (PHBOL); (C) PHB coated with phosphatidylglycerol and phosphatidylcholine (PHBPL). (Right panel) Quantification of elution efficiency by gel densitometry.

The affinity of PhaF to PHB was also quantified by a Langmuir analysis (Fig. 3). The binding isotherm acquired at 25°C reveals a maximum loading capacity of 20 ± 2 μg PhaF/mg PHB and a dissociation constant of 0.5 ± 0.1 mg/ml (18.3 μM) (Table 1). These values are similar to those from other PHA-binding proteins (37).

FIG 3.

FIG 3

Analysis of the saturation capacity of PHB preparations by Langmuir isotherm analysis. Each point in the plot represents the mean from three independent experiments.

TABLE 1.

Binding properties of PHB preparations for PhaFa

Material qmax (μg protein/mg PHB) Kd (mg/ml)
PHB 20 ± 2 0.5 ± 0.1
PHBOL 35 ± 3 0.4 ± 0.1
PHBPL 24 ± 4 1.0 ± 0.4
a

Calculated by Langmuir analysis (see Materials and Methods for the equation and Fig. 3).

PHB coating interferes with PhaF binding.

The mainly hydrophobic nature of the phasin-PHA binding interaction makes it interesting to evaluate the effect of covering the polyester with amphipathic compounds on the stability of PhaF adsorption. First, commercially available PHB particles were coated with oleic acid (PHBOL particles), a common component in artificial PHA preparations (38). Remarkably, the oleate cover somehow increases the affinity for PhaF, while significantly augmenting its maximum binding capacity (Table 1 and Fig. 3). This may be explained in terms of a specific stabilizing interaction between oleate molecules and PhaF that has been described before (34). Nevertheless, and for the same reason, the PhaF-loaded PHBOL particles were more sensitive to competing detergents whose structures mimic that of oleate (i.e., long hydrocarbon chains), namely, Triton X-100 and especially Tween 20 (Fig. 2B; see also Fig. S4). Finally, with the aim of mimicking the lipid layer inherently found in usual PHA preparations, PHB granules were coated with a 1:1 (wt/wt) lipid mixture of phosphatidylcholine and phosphatidylglycerol (PHBPL particles). In this case, the affinity for PhaF was severely diminished (Table 1 and Fig. 3), and the protein could be eluted with an appreciable yield by all tested detergents except CHAPS (Fig. 2C). To check for any possible destabilizing effect on the PHB particle caused by the phospholipid layer, we evaluated the aspect, stability, and degree of crystallinity of both lipid-treated and nontreated PHB materials by differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). Figure 4 and Table 2 show that the size and morphology of PHB granules did not appreciably change upon coating. Data in Table 2 also indicate that lipid coating produced only a moderate decrease in crystallinity (65% to 44%), even after the lyophilization step, while thermal stability and particle size were also largely unaffected. These results demonstrate that granule coatings by amphiphilic compounds affect the BioF-PHB interaction to variable extents without substantially affecting particle integrity.

FIG 4.

FIG 4

SEM micrographs of PHB and PHBPL preparations.

TABLE 2.

Calorimetric characterization of PHB preparations

Material Tma (°C) ΔHmb (J/g) Crystallinityc (%) Mass loss upon heating (%) Particle sized (μm)
PHB 173.3 ± 0.9 95 ± 3 65 20.0 0.5–1
PHBPL 173.0 ± 0.9 70 ± 20 44 25.5 0.3–0.9
a

Tm, melting temperature.

b

ΔHm, melting enthalpy.

c

Calculated according to reference 53.

d

By SEM.

Immobilization of BioF-tagged hybrid proteins on PHB.

The results shown so far indicate that the PhaF phasin is likely to bind to different types of PHAs, such as PHB. This adds a novel functionality for the BioF polypeptide to serve as a versatile affinity tag for anchoring recombinant proteins of interest to a wide range of polyhydroxyalkanoates. To further evaluate the biotechnological potential of this result, we analyzed the in vitro binding of the BioF–C-LytA protein (formerly named FLyt), a fusion of BioF with the C-LytA choline-binding module (32), to synthetic PHB granules. Only the binding of BioF–C-LytA to native mcl-PHA granules in vivo had been previously studied (32). As shown in Fig. 5, purified BioF–C-LytA was able to bind to PHB at 37°C with an affinity comparable to that of the PhaF phasin (77% of applied protein, see Fig. 1) and also independently of pH and ionic strength (data not shown). The stability against detergents followed a trend similar to that for PhaF, with sarcosyl and SDS being the most efficient eluting agents (see Fig. S5). Unexpectedly, the residual elution capability of Tween 20 for PhaF was not detected in the case of BioF–C-LytA. Nevertheless, this effect might be ascribed to secondary interactions taking place between the polymer and the relatively hydrophobic aromatic-rich C-LytA moiety (39) that is likely to strengthen the binding. On the other hand, in contrast to the PhaF case (Fig. 2), CHAPS was able to elute a small but detectable amount of BioF–C-LytA protein (Fig. S5). This is probably due to the fact that the quaternary ammonium group in the detergent (Fig. S4) may act as a specific choline-like ligand of the C-LytA moiety (40) and helps release the protein from the polymer. Importantly, while BioF–C-LytA is unstable in solution and shows evident signs of autodegradation at 37°C, a clear protective effect provided by the PHB matrix is evident when the protein is immobilized on the polymer (Fig. 5).

FIG 5.

FIG 5

(Left) Analysis by SDS-PAGE of the stability of BioF–C-LytA binding to PHB at 37°C. C, control of soluble protein; B, bound protein eluted from PHB with 1% (wt/vol) SDS after heating at 90°C for 10 min. Black arrows indicate degradation fragments of BioF–C-LytA in solution. (Right) Results of gel densitometry, shown as percentages of initial applied protein.

Construction of PHB-based enzymatic minibioreactors.

Once the capability and functionality of the BioF tag as an immobilization system of fusion proteins to commercial preparations of PHB were confirmed, we evaluated the possibility of using this platform for the construction of enzyme bioreactors. As a proof of concept, we assessed the performance of the hybrid protein BioF–β-galactosidase (formerly named FLac) in a PHB-based minibioreactor, where the BioF polypeptide is fused to the Escherichia coli β-galactosidase protein (32). Even though the BioF–β-galactosidase enzyme could only be purified to approximately 35% (Fig. S2), it still represents a suitable system, since the majority of industrial applications involving immobilized enzymes do not require a greater extent of protein purity (41). The partially purified BioF–β-galactosidase preparation was adsorbed on PHB, and the enzymatic activity was assayed in 14 reaction/washing cycles (10 min each), followed by two other cycles assayed after 48 and 96 h (Fig. 6). After such incubations, the enzymatic activity was still conserved at 75% ± 7% with respect to the initial activity, suggesting that the enzyme kept its stability under these conditions and that protein desorption from the matrix was not relevant.

FIG 6.

FIG 6

Activity of PHB-immobilized BioF–β-galactosidase during 16 continuous cycles. Time between cycles was 20 min, except for cycles 15 and 16, which were carried out after 48 and 96 h, respectively. Each experiment represents the mean from six determinations.

DISCUSSION

Polyhydroxyalkanoate-based technologies based on functionalization with proteins possess a high biotechnological potential that, nevertheless, has not yet found the expected industrial development and application. These limitations are particularly linked with the restrictions of the production systems. Therefore, to achieve a wide industrial application and performance comparable to those of other commercially available polymers, improved PHA-based protein immobilization platforms need to be developed (42). Moreover, the need for high-added-value applications and particularly the construction of bioactive PHA supports by means of protein functionalization might boost the commercial importance of PHA. Nevertheless, the construction of bioactive PHA systems by protein immobilization has been investigated to a limited degree at the laboratory scale and is still a nascent technology that needs scaling up for industrial applications (43). Very efficient covalent methods for PHA functionalization-based translational fusions with PhaC from Ralstonia eutropha have been described in detail by Rehm's group, leading to a variety of biotechnological and biomedical applications (3, 44, 45). However, in the case of noncovalent methods like those based in phasins, several key technical issues, such as control of PHA-protein association/dissociation and granule size, still remain unresolved.

Herein, we have evaluated the in vitro binding properties of the PHA-binding domain of the PhaF phasin from P. putida KT2440 (BioF tag) to scl-PHAs such as PHB particles devoid of any coating. The BioF-PHB interaction is very stable with respect to temperature (25 to 37°C) (Fig. 1), time (48 to 96 h) (Fig. 1, 5, and 6), pH (2 to 9) (Fig. S3 in the supplemental material), and detergent action (Fig. 2). Similar results were obtained with the fusion protein BioF–C-LytA (Fig. 5; see also Fig. S5), demonstrating that binding to PHB is mostly ascribed to the BioF sequence independently of the fused polypeptide. Furthermore, the binding of the fusion protein to PHA may strongly protect the adsorbed protein from degradation, as revealed for BioF–C-LytA (Fig. 5). Our results indicate that the BioF tag is especially suited to provide a robust and stable, yet straightforward, protein immobilization platform not only to its natural cognate mcl-PHA substrate but also to commercially available PHB and, probably, to many other PHA types. To date, only limited examples of phasin binding to pure noncoated PHA preparations have been reported (30, 46). However, more studies of this kind are necessary, since several applications, especially in the biomedical field, require homogeneous materials free of endotoxins or other incompatible components.

The molecular nature of the binding between BioF and mcl-PHAs is likely to be mainly based on hydrophobic, nonspecific interactions, according to the predicted secondary structure of the PhaF phasin (34). This structural model predicts that the BioF sequence folds into a long, tetrameric amphipathic α-helix that recognizes the surface of the PHA granule through the nonpolar face of the helix. As expected for a mainly hydrophobic interaction, the BioF-PHB binding is susceptible to detergent treatment. The efficiency of the detergent treatment strongly depends on the detergent type. The agents with the highest eluting performances are SDS and sarcosyl (Fig. 2; see also Fig. S5), which is in agreement with similar in vivo results when mcl-PHAs have been used as the immobilization substrate (32). Therefore, these should be the compounds of choice to eventually regenerate the PHB support in any biotechnological process that requires a new loading with fresh protein. Moreover, SDS and sarcosyl are also the detergents with the longest linear hydrocarbon moieties (Fig. S4), which are likely to better intercalate within the presumably elongated BioF-PHA interface (34). While Tween 20 also has a long linear hydrophobic chain, its polar moiety is sizeable, probably hampering the interaction with the hydrophobic side of the helix (Fig. S4). Consequently, this detergent displays an intermediate eluting behavior that is enhanced when the protein-granule interaction is weakened upon granule coating (Fig. 2). Finally, Triton X-100 and sodium cholate possess the shortest linear chains and subsequently show the poorest elution properties. CHAPS represents a peculiar case, because its structure is devoid of linear chains and, accordingly, does not elute PhaF from the PHB granule (Fig. 2). However, the binding of the BioF–C-LytA chimera is somehow susceptible to this detergent both in vitro (Fig. S5) and in vivo (32), probably because CHAPS behaves as a ligand of the C-LytA moiety and helps elute the protein by weakening a secondary non-BioF-related interaction. This indicates that the polypeptide fused to the BioF tag may also contribute, positively or negatively, to strength of the binding to PHA.

The BioF-PHB interaction is affected if the polyester is coated in vitro with amphiphilic compounds such as oleic acid and, especially, phospholipid layers (Fig. 2 and 3; Table 1). This dependence on granule coating has also been observed for the binding of the PhaP phasin from Ralstonia eutropha to polyhydroxyoctanoate surfaces, which was prevented by the presence of a phospholipid cover in the granule (46). Given its elongated shape, BioF is likely to be attached to the PHA polymer in parallel with its surface (34) but not deeply penetrating into the granule, as this would certainly impose an excessive desolvation energy penalty to the polar residues in the hydrophilic face of the helix. Hence, it is not surprising that any coating of the matrix should affect the direct association between the affinity tag and the polyester by decreasing the amount of available PHB surface. Far from constituting a drawback, this dependence on coating represents a useful characteristic to rationally modulate the strength of BioF-tagged protein adsorption and may find its application in processes requiring a fine tuning of the interactions, such as the controlled release of therapeutic proteins and peptides (47, 48) or the straightforward regeneration of enzymatic reactors after enzyme inactivation.

To date, the main applications of protein-functionalized PHAs have been aimed at biomedical purposes, such as diagnosis, vaccines, drug delivery, and cell imaging (42). However, the development of PHA-based enzymatic reactors has been analyzed to a very limited degree. Therefore, in this work, we have studied the enzymatic activity of the chimeric protein BioF–β-galactosidase immobilized on PHB particles as a proof of concept for the construction of these systems. Our procedure led to systems showing stable galactosidase activity during several continuous cycles of reaction/washing as well as an extended enzyme performance (at least 96 h) (Fig. 6). These results confirm the strong interaction between the BioF tag and PHB particles and pave the way for the construction of sustainable reusable PHA supports designed for enzymatic biotransformations.

MATERIALS AND METHODS

Bacterial strains, plasmids, and general growth conditions.

Liquid cultures of Escherichia coli were grown at 37°C in Luria-Bertani (LB) broth (49) supplemented with kanamycin (0.05 mg/ml) or streptomycin (0.05 mg/ml), depending on the plasmid resistance, in an orbital shaker (200 rpm; INNOVA 4000). Bacterial growth was followed by turbidimetry at 600 nm using an Evolution 201 spectrophotometer (Thermo Scientific).

Overproduction and purification of recombinant proteins.

As a general procedure, overexpression was carried out in every case in freshly transformed cells with the corresponding expression vector according to CaCl2 transformation protocols (49). The purity of protein preparations was checked by polyacrylamide gel electrophoresis under denaturing conditions (SDS-PAGE) (50) using the Mini-Protean systems from Bio-Rad. Gels were stained with EZBlue (Sigma-Aldrich). The concentration of pure proteins was assessed by absorption spectroscopy at 280 nm (Evolution 201; Thermo Scientific) with theoretical molar extinction coefficients of 19,071 M−1 · cm−1 (PhaF) and 109,320 M−1 · cm−1 (BioF–C-LytA) using the online software ProtParam from the ExPASy toolbox (http://web.expasy.org/protparam). Samples containing partially purified BioF–β-galactosidase were quantified by using the protein assay dye reagent concentrate from Bio-Rad and bovine serum albumin (Sigma-Aldrich) as the standard. Enzyme fractions were stored at −20°C until further use.

PhaF protein was overexpressed in E. coli BL21(DE3) cells harboring the pETPhaF plasmid and purified by hydrophobic interaction chromatography on butyl-Sepharose (GE Healthcare) as previously described (33).

For the purification of the Bio–C-LytA protein, E. coli CC118 cells harboring plasmid pNFA2 (32) were grown at 37°C and 200 rpm until the culture reached an optical density at 600 nm (OD600) of 0.6. Then, FLyt gene overexpression was induced for 14 h at 30°C by the addition of 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG). Cells were harvested by centrifugation at 4°C (10,000 × g), resuspended in 20 mM sodium phosphate (PNa) buffer (pH 7.0) plus 100 mM NaCl (50 ml per liter of culture), disrupted by sonication (Branson 250), and centrifuged again for 10 min at 4°C (10,000 × g). Insoluble inclusion bodies containing denatured BioF–C-LytA were redissolved in 8 M urea (25 ml per liter of culture), followed by centrifugation for 10 min at 4°C (10,000 × g). Simultaneous refolding and purification of BioF–C-LytA were accomplished in one step by directly loading the supernatant onto a Sephadex G-100 gel filtration column (50 cm by 1 cm; Bio-Rad), employing PNa buffer plus 100 mM NaCl as the mobile phase. Fractions with more than 90% purity, as assessed by SDS-PAGE, were stored at 4°C (Fig. S1 in the supplemental material).

The purification of the BioF–β-galactosidase fusion was accomplished by using E. coli CC118 cells harboring plasmid pNFL2 (32) grown and processed as for the BioF–C-LytA protein (see above), except that BioF–β-galactosidase protein was found predominantly in the soluble fraction after sonication. Ammonium sulfate was slowly added at 4°C with stirring to a final concentration of 1.7 M, and the solution was then centrifuged at 4°C (10,000 × g) and the supernatant was applied to a butyl Sepharose 4 fast flow column (GE Healthcare) (10 cm by 1 cm) previously equilibrated with PNa buffer containing 1.7 M ammonium sulfate. The column was thoroughly washed with PNa buffer plus 0.75 M ammonium sulfate, and then BioF–β-galactosidase was finally eluted with PNa buffer. The result of the partial purification is shown in Fig. S2, and the amount of BioF–β-galactosidase with respect to the total protein was estimated at 35% ± 3% upon gel densitometry using ImageJ (51). Attempts to further purify the protein were unsuccessful in our hands.

Preparation and characterization of coated PHB particles.

Artificial oleate-coated PHB granules (PHBOL) were prepared by the oil-in-water emulsion method as previously described (38). Artificial phospholipid-coated PHB granules (PHBPL) were prepared according to a previously described procedure (52) with minor modifications. First, 1 volume of 5% (wt/vol) PHB (Sigma-Aldrich) solution in chloroform was emulsified with 20 volumes of an aqueous solution of 2% (wt/vol) sodium cholate (Sigma-Aldrich) by ultrasonication (20 kHz, 1 to 3 min). Then, chloroform was removed from the emulsion under vacuum conditions (40°C for 60 min), and the artificial granules coated with sodium cholate were harvested by centrifugation (10,000 × g for 10 min) and washed twice with equal volumes of distilled water. Granules were resuspended with equal volumes of PNa buffer containing l-α-phosphatidyl-d-l-glycerol (5 mg/ml; Sigma-Aldrich) and l-α-phosphatidylcholine (5 mg/ml; Sigma-Aldrich) from egg yolk previously emulsified by sonication in an aqueous solution of 2% (wt/vol) sodium cholate. The resulting mixture was extensively dialyzed in 20 mM PNa buffer (pH 7.0) containing 25 g/liter Amberlite XAD-2 (Sigma-Aldrich) to remove sodium cholate. Finally, artificial phospholipid-coated PHB granules were concentrated by lyophilizing to dryness (Telstar Cryodos).

The characterization of the PHB material was achieved by thermal analysis. Samples of approximately 5 to 10 mg were placed in an aluminum capsule and subjected to differential scanning calorimetry (DSC) on a Pyris Diamond DSC calorimeter (PerkinElmer, Waltham, MA). The samples were heated under a nitrogen atmosphere from 20°C to 200°C at a rate of 20°C/min. The degree of crystallinity was estimated from the experimental melting enthalpies (ΔHm) assuming a value of 146 J/g for a 100% crystalline PHB (53). PHB particles were also analyzed by scanning electron microscopy (SEM) in a Phenom-World ProX microscope operating at 10 kV. Samples were placed in the microscope plate and sputter coated with gold to ensure electrical conductivity. Both SEM and DSC analyses were carried out in the Plastics Technology Centre AIMPLAS (Valencia, Spain).

Protein binding to PHB particles.

As a general methodology, 5-mg amounts from different preparations of PHB (PHB, PHBPL, or PHBOL) were incubated for 15 min with 20 to 30 μg of a BioF-containing protein (PhaF or BioF–C-LytA) in a final volume of 100 μl PNa buffer at a temperature of 25 or 37°C. After mild mixing on a digital rotary mixer (Ovan), the unbound protein fraction was separated from the polyester by centrifugation (10 min at 10,000 × g). PHB beads were washed five times with 500 μl PNa buffer plus 0.1 M NaCl and finally resuspended in 100 μl of PNa buffer. To check the strength of the protein-PHB interaction, the resuspension buffer contained the corresponding detergents: 1% (wt/vol) SDS, 3% (wt/vol) sarcosyl, 1% (wt/vol) Tween 20, 1% (vol/vol) Triton X-100, 3% (wt/vol) sodium cholate, and 3% (wt/vol) CHAPS (Sigma-Aldrich). After 15 min of incubation at 25°C, samples were centrifuged and the eluted protein fractions were analyzed by UV spectroscopy and SDS-PAGE.

To determine the affinity of the protein-PHB interaction and the maximum protein binding capacity by Langmuir analysis (54, 55), 10 mg of PHB was incubated with increasing concentrations of PhaF (0 to 2.5 mg/ml) in PNa buffer (500 μl). After mild mixing (30 min at 25°C) on a digital rotary mixer (Ovan), the unbound protein fraction was recovered from the polyester by centrifugation (10 min at 10,000 × g). The amount of PhaF bound to PHB (μg PhaF/mg PHB) was calculated by subtracting the unbound protein from the initial added protein. Data were fitted to the equation q = (qmaxC)/(Kd + C) (54, 55), where q is the amount of protein bound on PHB (μg protein/mg PHB), qmax is the maximum adsorption capacity of PHB granules (μg protein/mg PHB), C is the concentration of protein added (mg/ml), and Kd is the dissociation constant (mg/ml).

β-Galactosidase enzyme activity.

The β-galactosidase activity of the immobilized hybrid BioF–β-galactosidase protein was assayed spectrophotometrically according to Miller (56). BioF–β-galactosidase (approximately 2.5 μg, as estimated by gel densitometry [see above]) was first immobilized on 0.5 mg of PHB as described above for PhaF. After extensive washing with PNa buffer, the resin was incubated for 10 min at 25°C with 5 mM o-nitro-phenyl-β-d-galactopyranoside (ONPG) on a digital rotary mixer (Ovan). We previously checked that the enzymatic reaction was linear within these time limits (data not shown). The sample was then briefly centrifuged (10,000 × g), the supernatant was removed, and the reaction was stopped with 0.12 M Na2CO3. Enzymatic activity was assessed following the formation of o-nitrophenol at 420 nm (ε420 = 4,500 M−1 · cm−1), after subtracting a blank that was processed the same way but without the enzyme added. The remaining PHB support was extensively washed with PNa buffer to remove remaining traces of ONPG and o-nitrophenol and subjected to new enzymatic cycles by the addition of fresh 5 mM ONPG.

Supplementary Material

Supplemental material

ACKNOWLEDGMENTS

We thank M. Garzón, M. Gutiérrez, J. Casanova, N. Hernandez, and R. Aldomar for excellent technical assistance.

This work was supported by the Spanish Ministry of Economy and Competitiveness (grants BFU2010-17824, BIO2013-44878-R, BIO2013-47684-R, and BIO2016-79323-R) and the Community of Madrid (Spain) (NanoBIOSOMA S20 1473 3/M lT-2807).

Footnotes

Supplemental material for this article may be found at https://doi.org/10.1128/AEM.02595-17.

REFERENCES

  • 1.Rodríguez-Carmona E, Villaverde A. 2010. Nanostructured bacterial materials for innovative medicines. Trends Microbiol 18:423–430. doi: 10.1016/j.tim.2010.06.007. [DOI] [PubMed] [Google Scholar]
  • 2.Gagner JE, Kim W, Chaikof EL. 2014. Designing protein-based biomaterials for medical applications. Acta Biomater 10:1542–1557. doi: 10.1016/j.actbio.2013.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Rehm FB, Chen S, Rehm BH. 2016. Enzyme engineering for in situ immobilization. Molecules 21:E1370. doi: 10.3390/molecules21101370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Batalla P, Bolivar JM, Lopez-Gallego F, Guisan JM. 2012. Oriented covalent immobilization of antibodies onto heterofunctional agarose supports: a highly efficient immuno-affinity chromatography platform. J Chromatogr A 1262:56–63. doi: 10.1016/j.chroma.2012.08.058. [DOI] [PubMed] [Google Scholar]
  • 5.Barbosa O, Ortiz C, Berenguer-Murcia A, Torres R, Rodrigues RC, Fernandez-Lafuente R. 2015. Strategies for the one-step immobilization-purification of enzymes as industrial biocatalysts. Biotechnol Adv 33:435–456. doi: 10.1016/j.biotechadv.2015.03.006. [DOI] [PubMed] [Google Scholar]
  • 6.Steinbuchel A, Aerts K, Babel W, Follner C, Liebergesell M, Madkour MH, Mayer F, Pieper-Furst U, Pries A, Valentin HE. 1995. Considerations on the structure and biochemistry of bacterial polyhydroxyalkanoic acid inclusions. Can J Microbiol 41(Suppl 1):S94–S105. doi: 10.1139/m95-175. [DOI] [PubMed] [Google Scholar]
  • 7.Jendrossek D. 2009. Polyhydroxyalkanoate granules are complex subcellular organelles (carbonosomes). J Bacteriol 191:3195–3202. doi: 10.1128/JB.01723-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Keshavarz T, Roy I. 2010. Polyhydroxyalkanoates: bioplastics with a green agenda. Curr Opin Microbiol 13:321–326. doi: 10.1016/j.mib.2010.02.006. [DOI] [PubMed] [Google Scholar]
  • 9.Park SJ, Kim TW, Kim MK, Lee SY, Lim SC. 2012. Advanced bacterial polyhydroxyalkanoates: towards a versatile and sustainable platform for unnatural tailor-made polyesters. Biotechnol Adv 30:1196–1206. doi: 10.1016/j.biotechadv.2011.11.007. [DOI] [PubMed] [Google Scholar]
  • 10.Zinn M, Witholt B, Egli T. 2001. Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Adv Drug Deliv Rev 53:5–21. doi: 10.1016/S0169-409X(01)00218-6. [DOI] [PubMed] [Google Scholar]
  • 11.Yu J. 2014. Bio-based products from solar energy and carbon dioxide. Trends Biotechnol 32:5–10. doi: 10.1016/j.tibtech.2013.11.001. [DOI] [PubMed] [Google Scholar]
  • 12.Somleva MN, Peoples OP, Snell KD. 2013. PHA bioplastics, biochemicals, and energy from crops. Plant Biotechnol J 11:233–252. doi: 10.1111/pbi.12039. [DOI] [PubMed] [Google Scholar]
  • 13.Lenz RW, Marchessault RH. 2005. Bacterial polyesters: biosynthesis, biodegradable plastics and biotechnology. Biomacromolecules 6:1–8. doi: 10.1021/bm049700c. [DOI] [PubMed] [Google Scholar]
  • 14.Madison LL, Huisman GW. 1999. Metabolic engineering of poly(3-hydroxyalkanoates): from DNA to plastic. Microbiol Mol Biol Rev 63:21–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pötter M, Steinbuchel A. 2005. Poly(3-hydroxybutyrate) granule-associated proteins: impacts on poly(3-hydroxybutyrate) synthesis and degradation. Biomacromolecules 6:552–560. doi: 10.1021/bm049401n. [DOI] [PubMed] [Google Scholar]
  • 16.Anjum A, Zuber M, Zia KM, Noreen A, Anjum MN, Tabasum S. 2016. Microbial production of polyhydroxyalkanoates (PHAs) and its copolymers: a review of recent advancements. Int J Biol Macromol 89:161–174. doi: 10.1016/j.ijbiomac.2016.04.069. [DOI] [PubMed] [Google Scholar]
  • 17.McQualter RB, Somleva MN, Gebbie LK, Li X, Petrasovits LA, Snell KD, Nielsen LK, Brumbley SM. 2014. Factors affecting polyhydroxybutyrate accumulation in mesophyll cells of sugarcane and switchgrass. BMC Biotechnol 14:83. doi: 10.1186/1472-6750-14-83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Griebel R, Smith Z, Merrick JM. 1968. Metabolism of poly-beta-hydroxybutyrate. I. Purification, composition, and properties of native poly-beta-hydroxybutyrate granules from Bacillus megaterium. Biochemistry 7:3676–3681. [DOI] [PubMed] [Google Scholar]
  • 19.Parlane NA, Gupta SK, Rubio Reyes P, Chen S, Gonzalez-Miro M, Wedlock DN, Rehm BH. 29 August 2016. Self-assembled protein-coated polyhydroxyalkanoate beads: properties and biomedical applications. ACS Biomater Sci Eng doi: 10.1021/acsbiomaterials.6b00355. [DOI] [PubMed] [Google Scholar]
  • 20.Bresan S, Sznajder A, Hauf W, Forchhammer K, Pfeiffer D, Jendrossek D. 2016. Polyhydroxyalkanoate (PHA) granules have no phospholipids. Sci Rep 6:26612. doi: 10.1038/srep26612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Beeby M, Cho M, Stubbe J, Jensen GJ. 2012. Growth and localization of polyhydroxybutyrate granules in Ralstonia eutropha. J Bacteriol 194:1092–1099. doi: 10.1128/JB.06125-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jendrossek D, Pfeiffer D. 2014. New insights in the formation of polyhydroxyalkanoate granules (carbonosomes) and novel functions of poly(3-hydroxybutyrate). Environ Microbiol 16:2357–2373. doi: 10.1111/1462-2920.12356. [DOI] [PubMed] [Google Scholar]
  • 23.Maestro B, Sanz JM. 2017. Polyhydroxyalkanoate-associated phasins as phylogenetically heterogeneous, multipurpose proteins. Microb Biotechnol 10:1323–1337. doi: 10.1111/1751-7915.12718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mezzina MP, Pettinari MJ. 2016. Phasins, multifaceted polyhydroxyalkanoate granule-associated proteins. Appl Environ Microbiol 82:5060–5067. doi: 10.1128/AEM.01161-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chen SY, Chien YW, Chao YP. 2014. In vivo immobilization of d-hydantoinase in Escherichia coli. J Biosci Bioeng 118:78–81. doi: 10.1016/j.jbiosc.2013.12.020. [DOI] [PubMed] [Google Scholar]
  • 26.Banki MR, Gerngross TU, Wood DW. 2005. Novel and economical purification of recombinant proteins: intein-mediated protein purification using in vivo polyhydroxybutyrate (PHB) matrix association. Protein Sci 14:1387–1395. doi: 10.1110/ps.041296305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Barnard GC, McCool JD, Wood DW, Gerngross TU. 2005. Integrated recombinant protein expression and purification platform based on Ralstonia eutropha. Appl Environ Microbiol 71:5735–5742. doi: 10.1128/AEM.71.10.5735-5742.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Draper JL, Rehm BH. 2012. Engineering bacteria to manufacture functionalized polyester beads. Bioengineered 3:203–208. doi: 10.4161/bioe.19567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bäckström BT, Brockelbank JA, Rehm BH. 2007. Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein. BMC Biotechnol 7:3. doi: 10.1186/1472-6750-7-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yao YC, Zhan XY, Zhang J, Zou XH, Wang ZH, Xiong YC, Chen J, Chen GQ. 2008. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials 29:4823–4830. doi: 10.1016/j.biomaterials.2008.09.008. [DOI] [PubMed] [Google Scholar]
  • 31.Dong Y, Li P, Chen CB, Wang ZH, Ma P, Chen GQ. 2010. The improvement of fibroblast growth on hydrophobic biopolyesters by coating with polyhydroxyalkanoate granule binding protein PhaP fused with cell adhesion motif RGD. Biomaterials 31:8921–8930. doi: 10.1016/j.biomaterials.2010.08.001. [DOI] [PubMed] [Google Scholar]
  • 32.Moldes C, Garcia P, Garcia JL, Prieto MA. 2004. In vivo immobilization of fusion proteins on bioplastics by the novel tag BioF. Appl Environ Microbiol 70:3205–3212. doi: 10.1128/AEM.70.6.3205-3212.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Galán B, Dinjaski N, Maestro B, de Eugenio LI, Escapa IF, Sanz JM, Garcia JL, Prieto MA. 2011. Nucleoid-associated PhaF phasin drives intracellular location and segregation of polyhydroxyalkanoate granules in Pseudomonas putida KT2442. Mol Microbiol 79:402–418. doi: 10.1111/j.1365-2958.2010.07450.x. [DOI] [PubMed] [Google Scholar]
  • 34.Maestro B, Galan B, Alfonso C, Rivas G, Prieto MA, Sanz JM. 2013. A new family of intrinsically disordered proteins: structural characterization of the major phasin PhaF from Pseudomonas putida KT2440. PLoS One 8:e56904. doi: 10.1371/journal.pone.0056904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Moldes C, Farinos GP, de Eugenio LI, Garcia P, Garcia JL, Ortego F, Hernandez-Crespo P, Castanera P, Prieto MA. 2006. New tool for spreading proteins to the environment: Cry1Ab toxin immobilized to bioplastics. Appl Microbiol Biotechnol 72:88–93. doi: 10.1007/s00253-005-0257-6. [DOI] [PubMed] [Google Scholar]
  • 36.Dinjaski N, Prieto MA. 2013. Swapping of phasin modules to optimize the in vivo immobilization of proteins to medium-chain-length polyhydroxyalkanoate granules in Pseudomonas putida. Biomacromolecules 14:3285–3293. doi: 10.1021/bm4008937. [DOI] [PubMed] [Google Scholar]
  • 37.Ohura T, Kasuya KI, Doi Y. 1999. Cloning and characterization of the polyhydroxybutyrate depolymerase gene of Pseudomonas stutzeri and analysis of the function of substrate-binding domains. Appl Environ Microbiol 65:189–197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wang Z, Wu H, Chen J, Zhang J, Yao Y, Chen GQ. 2008. A novel self-cleaving phasin tag for purification of recombinant proteins based on hydrophobic polyhydroxyalkanoate nanoparticles. Lab Chip 8:1957–1962. doi: 10.1039/b807762b. [DOI] [PubMed] [Google Scholar]
  • 39.Maestro B, Sanz JM. 2016. Choline-binding proteins from Streptococcus pneumoniae: a dual role as enzybiotics and targets for the design of new antimicrobials. Antibiotics (Basel) 5:E21. doi: 10.3390/antibiotics5020021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Maestro B, Gonzalez A, Garcia P, Sanz JM. 2007. Inhibition of pneumococcal choline-binding proteins and cell growth by esters of bicyclic amines. FEBS J 274:364–376. doi: 10.1111/j.1742-4658.2006.05584.x. [DOI] [PubMed] [Google Scholar]
  • 41.Aehle W. 2004. Enzymes in industry. Wiley-VCH, Weinheim, Germany. [Google Scholar]
  • 42.Dinjaski N, Prieto MA. 2015. Smart polyhydroxyalkanoate nanobeads by protein based functionalization. Nanomedicine 11:885–899. doi: 10.1016/j.nano.2015.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ihssen J, Magnani D, Thony-Meyer L, Ren Q. 2009. Use of extracellular medium chain length polyhydroxyalkanoate depolymerase for targeted binding of proteins to artificial poly[(3-hydroxyoctanoate)-co-(3-hydroxyhexanoate)] granules. Biomacromolecules 10:1854–1864. doi: 10.1021/bm9002859. [DOI] [PubMed] [Google Scholar]
  • 44.Rubio Reyes P, Parlane NA, Wedlock DN, Rehm BH. 2016. Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines. Int J Med Microbiol 306:624–632. doi: 10.1016/j.ijmm.2016.10.002. [DOI] [PubMed] [Google Scholar]
  • 45.Rubio-Reyes P, Parlane NA, Buddle BM, Wedlock DN, Rehm BHA. 2017. Immunological properties and protective efficacy of a single mycobacterial antigen displayed on polyhydroxybutyrate beads. Microb Biotechnol 10:1434–1440. doi: 10.1111/1751-7915.12754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wieczorek R, Pries A, Steinbuchel A, Mayer F. 1995. Analysis of a 24-kilodalton protein associated with the polyhydroxyalkanoic acid granules in Alcaligenes eutrophus. J Bacteriol 177:2425–2435. doi: 10.1128/jb.177.9.2425-2435.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pisal DS, Kosloski MP, Balu-Iyer SV. 2010. Delivery of therapeutic proteins. J Pharm Sci 99:2557–2575. doi: 10.1002/jps.22054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Patel A, Patel M, Yang X, Mitra AK. 2014. Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett 21:1102–1120. doi: 10.2174/0929866521666140807114240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
  • 50.Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 51.Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Horowitz DM, Sanders JKM. 1994. Amorphous, biomimetic granules of polyhydroxybutyrate: preparation, characterization, and biological implications. J Am Chem Soc 116:2695–2702. doi: 10.1021/ja00086a001. [DOI] [Google Scholar]
  • 53.Hu S, McDonald AG, Coats ER. 2013. Characterization of polyhydroxybutyrate biosynthesized from crude glycerol waste using mixed microbial consortia. J Appl Polym Sci 129:1314–1321. doi: 10.1002/app.38820. [DOI] [Google Scholar]
  • 54.Hung CW, Holoman TR, Kofinas P, Bentley WE. 2008. Towards oriented assembly of proteins onto magnetic nanoparticles. Biochem Eng J 38:164–170. doi: 10.1016/j.bej.2007.06.017. [DOI] [Google Scholar]
  • 55.Langmuir I. 1916. The constitution and fundamental properties of solids and liquids. J Am Chem Soc 38:2221–2295. doi: 10.1021/ja02268a002. [DOI] [Google Scholar]
  • 56.Miller JH. 1972. Assay of β-galactosidase. In Miller JH. (ed), Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental material

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES